Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

DOI

10.1080/13543776.2016.1206527

Type

Journal article

Journal

Expert opinion on therapeutic patents

Publication Date

09/2016

Volume

26

Pages

973 - 977

Addresses

a Department of Drug Design , University of Groningen , Groningen , The Netherlands.

Keywords

Animals, Humans, Neoplasms, Antineoplastic Agents, Immunotherapy, Drug Design, Patents as Topic, Programmed Cell Death 1 Receptor, B7-H1 Antigen